Keywords: complegen, berlex, sign, discovery, deal, genetics, based

CompleGen and Berlex sign discovery deal

Article | 14 April 2003

Print This

CompleGen, a genetics based drug discovery company, and BerlexBiosciences, a US affiliate of Germany's Schering AG, have entered into an ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in